Neurocrine Biosciences Inc (NBIX)

Trade NBIX now with
5/20/2019 8:05:34 AM Neurocrine Biosciences Presents New Data From RE-KINECT
5/5/2019 10:30:23 AM Neurocrine And Voyager Therapeutics Announce Phase I Results For VY-AADC In Patients With Parkinson's Disease
5/5/2019 10:29:55 AM Neurocrine Announces Presentation Of Data Analysis From Two Phase III Studies Of Opicapone
4/29/2019 4:04:38 PM Neurocrine Biosciences Q1 Loss/share $1.12 Vs. Loss $0.47 Year Ago
3/12/2019 8:02:52 AM Neurocrine Reports Interim Results From PhaseII Study Of NBI-74788 In Adults With Classic Congenital Adrenal Hyperplasia
2/5/2019 4:04:29 PM Neurocrine Biosciences Q4 EPS $0.19 Vs. $0.07 Year Ago
1/29/2019 7:07:31 AM Neurocrine Biosciences And Voyager Therapeutics Form Strategic Collaboration
1/28/2019 4:02:43 PM Insulet Adds Corinne Nevinny To Board
1/6/2019 7:36:10 PM Neurocrine Biosciences Expects Q4 Net Product Sales To Be About $130 Mln Vs $64.5 Mln Last Year
12/12/2018 7:34:01 AM PhaseIIb T-Force GOLD Study Shows Valbenazine Fails To Meet PrimaryEndpoint In Pediatric Patients With Tourette Syndrome